Literature DB >> 2154742

Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.

D T Chalmers1, D Dewar, D I Graham, D N Brooks, J McCulloch.   

Abstract

Involvement of cortical glutamatergic mechanisms in senile dementia of the Alzheimer type (SDAT) has been investigated with quantitative ligand-binding autoradiography. The distribution and density of Na(+)-dependent glutamate uptake sites and glutamate receptor subtypes--kainate, quisqualate, and N-methyl-D-aspartate--were measured in adjacent sections of frontal cortex obtained postmortem from six patients with SDAT and six age-matched controls. The number of senile plaques was determined in the same brain region. Binding of D-[3H]aspartate to Na(+)-dependent uptake sites was reduced by approximately 40% throughout SDAT frontal cortex relative to controls, indicating a general loss of glutamatergic presynaptic terminals. [3H]Kainate receptor binding was significantly increased by approximately 70% in deep layers of SDAT frontal cortex compared with controls, whereas this binding was unaltered in superficial laminae. There was a positive correlation (r = 0.914) between kainate binding and senile plaque number in deep cortical layers. Quisqualate receptors, as assessed by 2-amino-3-hydroxy-5-[3H]methylisoxazole-4-propionic acid binding, were unaltered in SDAT frontal cortex compared with controls. There was a small reduction (25%) in N-methyl-D-aspartate-sensitive [3H]glutamate binding only in superficial cortical layers of SDAT brains relative to control subjects. [3H]Glutamate binding in SDAT subjects was unrelated to senile plaque number in superficial cortical layers (r = 0.104). These results indicate that in the presence of cortical glutamatergic terminal loss in SDAT plastic alterations occur in some glutamate receptor subtypes but not in others.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154742      PMCID: PMC53473          DOI: 10.1073/pnas.87.4.1352

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Cortical GABAB and GABAA receptors in Alzheimer's disease: a quantitative autoradiographic study.

Authors:  D C Chu; J B Penney; A B Young
Journal:  Neurology       Date:  1987-09       Impact factor: 9.910

2.  Loss of hippocampal [3H]TCP binding in Alzheimer's disease.

Authors:  W F Maragos; D C Chu; A B Young; C J D'Amato; J B Penney
Journal:  Neurosci Lett       Date:  1987-03-09       Impact factor: 3.046

3.  [3H]TCP binding sites in Alzheimer's disease.

Authors:  D T Monaghan; J W Geddes; D Yao; C Chung; C W Cotman
Journal:  Neurosci Lett       Date:  1987-01-14       Impact factor: 3.046

4.  Blockade of "NMDA" receptors disrupts experience-dependent plasticity of kitten striate cortex.

Authors:  A Kleinschmidt; M F Bear; W Singer
Journal:  Science       Date:  1987-10-16       Impact factor: 47.728

Review 5.  Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamate.

Authors:  S I Deutsch; J M Morihisa
Journal:  Clin Neuropharmacol       Date:  1988-02       Impact factor: 1.592

6.  Huntington's disease: increased number and altered regulation of benzodiazepine receptor complexes in frontal cerebral cortex.

Authors:  R R Trifiletti; A M Snowman; P J Whitehouse; K A Marcus; S H Snyder
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

7.  Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.

Authors:  B Horwitz; C L Grady; N L Schlageter; R Duara; S I Rapoport
Journal:  Brain Res       Date:  1987-03-31       Impact factor: 3.252

8.  Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.

Authors:  R Cowburn; J Hardy; P Roberts; R Briggs
Journal:  Neurosci Lett       Date:  1988-03-21       Impact factor: 3.046

9.  Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease.

Authors:  J W Geddes; H Chang-Chui; S M Cooper; I T Lott; C W Cotman
Journal:  Brain Res       Date:  1986-12-03       Impact factor: 3.252

10.  Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.

Authors:  J T Greenamyre; J B Penney; C J D'Amato; A B Young
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

View more
  10 in total

1.  Laminar distribution of the multiple opioid receptors in the human cerebral cortex.

Authors:  J M Hiller; L Q Fan
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

Review 2.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

3.  Effect of nicotine on the level of extracellular amino acids in the hippocampus of rat.

Authors:  E Toth
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

4.  Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.

Authors:  Guilian Tian; Qiongman Kong; Liching Lai; Abhik Ray-Chaudhury; Chien-liang G Lin
Journal:  J Neurochem       Date:  2010-02-27       Impact factor: 5.372

5.  Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases.

Authors:  Chien-Liang Glenn Lin; Qiongman Kong; Gregory D Cuny; Marcie A Glicksman
Journal:  Future Med Chem       Date:  2012-09       Impact factor: 3.808

6.  Effect of latent iron deficiency on GABA and glutamate neuroreceptors in rat brain.

Authors:  Rama Devi Mittal; Amita Pandey; Balraj Mittal; Kailash Nath Agarwal
Journal:  Indian J Clin Biochem       Date:  2003-01

7.  Effect of latent iron deficiency on gaba and glutamate neuroreceptors in rat brain.

Authors:  Rama Devi Mittal; Amita Pandey; Balraj Mittal; Kailash Nath Agarwal
Journal:  Indian J Clin Biochem       Date:  2002-07

Review 8.  Neuropathobiology of senile dementia and mechanism of action of nootropic drugs.

Authors:  O Benesová
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 9.  Therapeutic potential of kainate receptors.

Authors:  Carlos Matute
Journal:  CNS Neurosci Ther       Date:  2010-12-06       Impact factor: 5.243

Review 10.  Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide.

Authors:  Rachelle Balez; Lezanne Ooi
Journal:  Oxid Med Cell Longev       Date:  2015-11-30       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.